Immunosuppressive activity of angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease
Language English Country England, Great Britain Media print
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Lymphocyte Activation drug effects MeSH
- Cell Division drug effects MeSH
- Embryonic and Fetal Development drug effects MeSH
- Endoribonucleases pharmacology MeSH
- Immunosuppressive Agents pharmacology MeSH
- Humans MeSH
- Mice MeSH
- Tumor Cells, Cultured drug effects MeSH
- Ribonuclease, Pancreatic pharmacology MeSH
- Proteins pharmacology MeSH
- Cattle MeSH
- Spermatogenesis drug effects MeSH
- Pregnancy MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Mice MeSH
- Cattle MeSH
- Pregnancy MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- angiogenin MeSH Browser
- Endoribonucleases MeSH
- Immunosuppressive Agents MeSH
- Ribonuclease, Pancreatic MeSH
- Proteins MeSH
- ribonuclease SPL MeSH Browser
Angiogenin, a member of the pancreatic-like ribonuclease family with a special biological action (RISBAses), is a basic protein that induces blood vessel formation. Another member of these special ribonucleases, bovine seminal ribonuclease (BS RNase), displays biological properties, including aspermatogenic, embryotoxic, antitumor and immunosuppressive activities. The effects of two angiogenin preparations tested on the biological activities mentioned above are reported and compared with those of BS RNase and RNase A. In contrast to RNase A, which was ineffective in all biological activities tested, angiogenin suppressed significantly the proliferation of human lymphocytes stimulated by phytohemagglutinin or concanavalin A or by allogenic human lymphocytes (mixed lymphocyte culture). However, angiogenin did not affect the growth of human tumor cell lines, development of cow and mouse embryos and spermatogenicity in mice. On the basis of these results, angiogenin is the first monomeric ribonuclease described so far that displays immunosuppressive activity similar to that of the dimeric BS RNase. The immunosuppressive activity of angiogenin might synergize with the effect on neovascularization of tumor tissues and thus contribute to the development of tumor.
References provided by Crossref.org